Skip to main content Accessibility help

Seroprevalence of Taenia solium infections in Croatian patients presenting with epilepsy

  • T. Meštrović (a1), M. Sviben (a2), T. Vilibić-Čavlek (a2), S. Ljubin-Sternak (a2), I. Tabain (a2) and G. Mlinarić-Galinović (a2)...


Epilepsy is one of the most common neurological disorders, while neurocysticercosis caused by Taenia solium infection of the central nervous system currently represents the leading cause of secondary epilepsy in Central and South America, East and South Asia, and sub-Saharan Africa. As a result of increased migration from these endemic regions, neurocysticercosis and subsequent epilepsy are becoming a growing public health problem in developed countries as well. In order to determine the prevalence of T. solium infection in patients with epilepsy in Croatia, a retrospective serological study was conducted. A total of 770 serum samples were tested for the presence of T. solium IgG antibodies using a commercial qualitative enzyme immunoassay. The Western blot technique was used as a confirmatory test for the diagnosis. The overall seroprevalence rate of T. solium infection in patients with clinically proven epilepsy was 1.5%. Although the results have shown that infection with this tapeworm is rare in Croatia, this study hopes to increase awareness about the importance of preventive measures and benefits of accurate and timely diagnosis. Intervention measures for infection control are crucial, namely sanitation improvement, control of domestic pig-breeding, detailed meat inspection, detection and treatment of tapeworm carriers, hand washing and health education.


Corresponding author

*Fax +385 1 4683 017 E-mail:


Hide All
Carpio, A. (2002) Neurocysticercosis: an update. Lancet Infectious Diseases 2, 751762.
Chopra, J.S., Kaur, U. & Mahajan, R.C. (1981) Cysticercosis and epilepsy: a clinical and serological study. Transactions of the Royal Society of Tropical Medicine and Hygiene 75, 518520.
Commision on Tropical Diseases of the International League Against Epilepsy (1994) Relationship between epilepsy and tropical diseases. Epilepsia 35, 8993.
Del Bruto, O.H., Santibanez, R., Noboa, C.A., Aguirre, R., Diaz, E. & Alarcon, T.A. (1992) Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 42, 389392.
Eddi, C., Nari, A. & Amanfu, W. (2003) Taenia solium cysticercosis/taeniosis: potential linkage with FAO activities; FAO support possibilities. Acta Tropica 87, 145148.
Flisser, A. (1994) Taeniasis and cysticercosis due to T. solium. pp. 77116in Sun, T. (Ed.) Progress in clinical parasitology. New York, CRC Press.
Garcia, H.H., Gilman, R., Herrera, G., Diaz, F., Miranda, E., Gilman, R., Martinez, M., Alvarado, M., Tsang, V.C.W. & Pilcher, J.B. (1993) Cysticercosis as a major cause of epilepsy in Peru. Lancet 341, 197200.
Garcia, H.H., Gonzalez, A.E., Evans, C.A.W. & Gilman, R.H. (2003) Taenia solium cysticercosis. Lancet 361, 547556.
Gekeler, F., Eichenlaub, S., Mendoza, E.G., Sotelo, J., Hoelscher, M. & Löscher, T. (2002) Sensitivity and specificity of ELISA and immunoblot for diagnosing neurocysticercosis. European Journal of Clinical Microbiology & Infectious Diseases 21, 227229.
Goel, D., Dhanai, J.S., Agarwal, A., Mehlotra, V. & Saxena, V. (2011) Neurocysticercosis and its impact on crude prevalence rate of epilepsy in an Indian community. Neurology India 59, 3740.
Mandal, J., Singhi, P.D., Khandelwal, N. & Malla, N. (2006) Evaluation of ELISA and dot blots for the serodiagnosis of neurocysticercosis, in children found to have single or multiple enhancing lesions in computerized tomographic scans of the brain. Annals of Tropical Medicine and Parasitology 100, 3948.
Medina, M.T., Rosas, E., Rubio-Donnadieu, F. & Sotelo, J. (1990) Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Archives of Internal Medicine 150, 325327.
Palacio, L.G., Jiménez, I., Garcia, H.H., Jiménez, M.E., Sánchez, J.L., Noh, J., Ahn, L., Mora, O., Giraldo, M. & Tsang, V.C. (1998) Neurocysticercosis in persons with epilepsy in Medellín, Colombia. The Neuroepidemiological Research Group of Antioquia. Epilepsia 39, 13341339.
Raccurt, C.P., Agnamey, P., Boncy, J., Henrys, J.-H. & Totet, A. (2009) Seroprevalence of human Taenia solium cysticercosis in Haiti. Journal of Helminthology 83, 113116.
Román, G., Sotelo, J., Del Bruto, O., Flisser, A., Dumas, M., Wadia, N., Botero, D., Cruz, M., Garcia, H.H., de Bittencourt, P.R.M., Trelles, L., Arriagada, C., Lorenzana, P., Nash, T.E. & Spina-França, A. (2000) A proposal to declare neurocysticercosis an international reportable disease. Bulletin of the World Health Organization 78, 399406.
Rousseau, M.C., Guillotel, B. & Delmont, J. (1999) Neurocysticercosis in the South-East of France 1988–1998. La Presse Médicale 39, 21412144(in French).
Schantz, P.M., Wilkins, P.P. & Tsang, V.C.W. (1998) Immigrants, imaging and immunoblots: the emergence of neurocysticercosis as a significant public health problem. pp. 213241in Scheld, W.M., Craig, W.A. & Hughes, J.M. (Eds) Emerging infections 2. Washington DC, ASM Press.
Scott, R.A., Lhatoo, S.D. & Sander, J.W. (2001) The treatment of epilepsy in developing countries: where do we go from here? Bulletin of the World Health Organization 79, 344351.
Serrano Ocana, G., Ortiz Sablon, J.C., Ochoa Tamayo, I., Almaguer Arena, L., Serrano Ocana, L.M. & Govender, S. (2009) Neurocysticercosis in patients presenting with epilepsy at St Elizabeth's Hospital, Lusikisiki. The South African Medical Journal 99, 588591.
White, A.C. Jr (2000) Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annual Review of Medicine 51, 187206.
Willingham, A.L. 3rd & Engels, D. (2006) Control of Taenia solium cysticercosis/taeniosis. Advances in Parasitology 61, 509566.

Related content

Powered by UNSILO

Seroprevalence of Taenia solium infections in Croatian patients presenting with epilepsy

  • T. Meštrović (a1), M. Sviben (a2), T. Vilibić-Čavlek (a2), S. Ljubin-Sternak (a2), I. Tabain (a2) and G. Mlinarić-Galinović (a2)...


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.